

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.55736825 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.15500922 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.10418941 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.10418941 |
| 5 | actin-myosin filament sliding (GO:0033275) | 4.63571138 |
| 6 | muscle filament sliding (GO:0030049) | 4.63571138 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.54799012 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.31670192 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 4.27970355 |
| 10 | skeletal muscle contraction (GO:0003009) | 4.13660332 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 3.96533579 |
| 12 | skeletal muscle adaptation (GO:0043501) | 3.94372972 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85290383 |
| 14 | viral transcription (GO:0019083) | 3.82126404 |
| 15 | positive thymic T cell selection (GO:0045059) | 3.80161917 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.75566893 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.75566893 |
| 18 | B cell receptor signaling pathway (GO:0050853) | 3.73745864 |
| 19 | cytidine metabolic process (GO:0046087) | 3.68395757 |
| 20 | cytidine catabolic process (GO:0006216) | 3.68395757 |
| 21 | cytidine deamination (GO:0009972) | 3.68395757 |
| 22 | translational termination (GO:0006415) | 3.61701664 |
| 23 | mannose metabolic process (GO:0006013) | 3.59221400 |
| 24 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.53207928 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 3.49027072 |
| 26 | actin-mediated cell contraction (GO:0070252) | 3.48350140 |
| 27 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.47224973 |
| 28 | regulation of B cell differentiation (GO:0045577) | 3.46004169 |
| 29 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44726119 |
| 30 | DNA deamination (GO:0045006) | 3.41733753 |
| 31 | translational elongation (GO:0006414) | 3.36510250 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33828486 |
| 33 | IMP metabolic process (GO:0046040) | 3.31285674 |
| 34 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30009820 |
| 35 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.27167962 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.24325890 |
| 37 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.19411321 |
| 38 | positive regulation of histone deacetylation (GO:0031065) | 3.16244274 |
| 39 | IMP biosynthetic process (GO:0006188) | 3.13501433 |
| 40 | regulation of antigen processing and presentation (GO:0002577) | 3.09919890 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08747976 |
| 42 | ribosomal small subunit biogenesis (GO:0042274) | 3.06279415 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04965183 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.98779123 |
| 45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.98487985 |
| 46 | definitive hemopoiesis (GO:0060216) | 2.96019391 |
| 47 | positive regulation of defense response to virus by host (GO:0002230) | 2.95816726 |
| 48 | defense response to protozoan (GO:0042832) | 2.95170649 |
| 49 | B cell mediated immunity (GO:0019724) | 2.94702385 |
| 50 | response to protozoan (GO:0001562) | 2.93436719 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 2.93428664 |
| 52 | GDP-mannose metabolic process (GO:0019673) | 2.92994470 |
| 53 | viral life cycle (GO:0019058) | 2.92117990 |
| 54 | purine nucleotide salvage (GO:0032261) | 2.91520987 |
| 55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.89617801 |
| 56 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89523836 |
| 57 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.88334267 |
| 58 | protein targeting to ER (GO:0045047) | 2.87770191 |
| 59 | cellular response to zinc ion (GO:0071294) | 2.87346166 |
| 60 | negative regulation of interleukin-12 production (GO:0032695) | 2.86456338 |
| 61 | translational initiation (GO:0006413) | 2.85211477 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 2.85184936 |
| 63 | cotranslational protein targeting to membrane (GO:0006613) | 2.84993446 |
| 64 | maturation of SSU-rRNA (GO:0030490) | 2.84862512 |
| 65 | response to peptidoglycan (GO:0032494) | 2.82773258 |
| 66 | cellular response to exogenous dsRNA (GO:0071360) | 2.82665946 |
| 67 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.82308990 |
| 68 | response to muramyl dipeptide (GO:0032495) | 2.82235948 |
| 69 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.81867861 |
| 70 | detection of bacterium (GO:0016045) | 2.78917496 |
| 71 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.78676872 |
| 72 | thymic T cell selection (GO:0045061) | 2.76922244 |
| 73 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.74602874 |
| 74 | macrophage activation involved in immune response (GO:0002281) | 2.74354265 |
| 75 | interferon-gamma secretion (GO:0072643) | 2.74162595 |
| 76 | positive regulation of protein deacetylation (GO:0090312) | 2.73937470 |
| 77 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.71623411 |
| 78 | natural killer cell differentiation (GO:0001779) | 2.69933036 |
| 79 | protein localization to endoplasmic reticulum (GO:0070972) | 2.68506166 |
| 80 | striated muscle atrophy (GO:0014891) | 2.68029834 |
| 81 | negative thymic T cell selection (GO:0045060) | 2.67787198 |
| 82 | formation of translation preinitiation complex (GO:0001731) | 2.66531400 |
| 83 | leukocyte aggregation (GO:0070486) | 2.64983213 |
| 84 | T cell migration (GO:0072678) | 2.64960308 |
| 85 | actin filament-based movement (GO:0030048) | 2.64852150 |
| 86 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.64651035 |
| 87 | response to interleukin-15 (GO:0070672) | 2.64226462 |
| 88 | cellular protein complex disassembly (GO:0043624) | 2.64098725 |
| 89 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.63434382 |
| 90 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.63434382 |
| 91 | modulation by symbiont of host immune response (GO:0052553) | 2.63434382 |
| 92 | positive regulation by symbiont of host defense response (GO:0052509) | 2.63434382 |
| 93 | modulation by symbiont of host defense response (GO:0052031) | 2.63434382 |
| 94 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.63434382 |
| 95 | response to type I interferon (GO:0034340) | 2.62602202 |
| 96 | negative regulation of innate immune response (GO:0045824) | 2.62550626 |
| 97 | detection of other organism (GO:0098543) | 2.61435927 |
| 98 | cellular response to interleukin-15 (GO:0071350) | 2.61305442 |
| 99 | regulation of defense response to virus by host (GO:0050691) | 2.60495235 |
| 100 | type I interferon signaling pathway (GO:0060337) | 2.59398663 |
| 101 | cellular response to type I interferon (GO:0071357) | 2.59398663 |
| 102 | mature B cell differentiation involved in immune response (GO:0002313) | 2.59334925 |
| 103 | positive regulation of type 2 immune response (GO:0002830) | 2.58235361 |
| 104 | skeletal muscle tissue regeneration (GO:0043403) | 2.58050306 |
| 105 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.57299496 |
| 106 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.56837776 |
| 107 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.55625080 |
| 108 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.55248223 |
| 109 | muscle atrophy (GO:0014889) | 2.54786025 |
| 110 | neutrophil activation involved in immune response (GO:0002283) | 2.53784339 |
| 111 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.52517674 |
| 112 | lymph node development (GO:0048535) | 2.50362678 |
| 113 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.49894148 |
| 114 | mature B cell differentiation (GO:0002335) | 2.49496721 |
| 115 | actin nucleation (GO:0045010) | 2.48723357 |
| 116 | negative T cell selection (GO:0043383) | 2.48691373 |
| 117 | regulation of mast cell degranulation (GO:0043304) | 2.47502791 |
| 118 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.46716062 |
| 119 | purine-containing compound salvage (GO:0043101) | 2.45415818 |
| 120 | T cell costimulation (GO:0031295) | 2.45245572 |
| 121 | positive regulation of chemokine secretion (GO:0090197) | 2.44824635 |
| 122 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.44704466 |
| 123 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.44632065 |
| 124 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.44374455 |
| 125 | regulation of T cell tolerance induction (GO:0002664) | 2.44187196 |
| 126 | skeletal muscle fiber development (GO:0048741) | 2.43506790 |
| 127 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.43402329 |
| 128 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.43402329 |
| 129 | valine metabolic process (GO:0006573) | 2.43354466 |
| 130 | granulocyte activation (GO:0036230) | 2.42810242 |
| 131 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.41961993 |
| 132 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.41547146 |
| 133 | tolerance induction (GO:0002507) | 2.41423246 |
| 134 | N-acetylneuraminate metabolic process (GO:0006054) | 2.41346728 |
| 135 | lymphocyte costimulation (GO:0031294) | 2.40673402 |
| 136 | negative regulation of granulocyte differentiation (GO:0030853) | 2.39895056 |
| 137 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.38981437 |
| 138 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.38946671 |
| 139 | T cell selection (GO:0045058) | 2.38261920 |
| 140 | Peyers patch development (GO:0048541) | 2.38080582 |
| 141 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.38080582 |
| 142 | T cell homeostasis (GO:0043029) | 2.37894902 |
| 143 | negative regulation of necroptotic process (GO:0060546) | 2.37473976 |
| 144 | protein complex disassembly (GO:0043241) | 2.36540753 |
| 145 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.36365315 |
| 146 | regulation of necroptotic process (GO:0060544) | 2.36283518 |
| 147 | positive T cell selection (GO:0043368) | 2.31567257 |
| 148 | regulation of response to interferon-gamma (GO:0060330) | 2.31097043 |
| 149 | lymphocyte homeostasis (GO:0002260) | 2.30375779 |
| 150 | germinal center formation (GO:0002467) | 2.29751193 |
| 151 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.28833602 |
| 152 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.27952035 |
| 153 | morphogenesis of an endothelium (GO:0003159) | 2.27213858 |
| 154 | endothelial tube morphogenesis (GO:0061154) | 2.27213858 |
| 155 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.25813845 |
| 156 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.23533656 |
| 157 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.22148599 |
| 158 | positive regulation of interferon-alpha production (GO:0032727) | 2.22089606 |
| 159 | sequestering of actin monomers (GO:0042989) | 2.21743940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.71774204 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.17938058 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.96523351 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.72668879 |
| 5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.65632213 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47933341 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47567604 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46205256 |
| 9 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.33975317 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.24734957 |
| 11 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21935914 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.21095728 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09272081 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.04661856 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04446602 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.03952153 |
| 17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01107781 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00573738 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94317038 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.91275049 |
| 21 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90771227 |
| 22 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.89448106 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.88860067 |
| 24 | P68_20966046_ChIP-Seq_HELA_Human | 1.83087648 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80233673 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80217306 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77644357 |
| 28 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.77571753 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.76180535 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76115975 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74942992 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73332629 |
| 33 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73130626 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66941581 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66919743 |
| 36 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.62766714 |
| 37 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62553519 |
| 38 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.62365562 |
| 39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.61659909 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61495100 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59995070 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.59604130 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58643380 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57741217 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.52779852 |
| 46 | MYB_26560356_Chip-Seq_TH2_Human | 1.52083281 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51544762 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.51510126 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.50292901 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50280231 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49919312 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48413228 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.47819259 |
| 54 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47106311 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45925533 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45239046 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44767145 |
| 58 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.44308639 |
| 59 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.44139265 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40199147 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39725091 |
| 62 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.39166278 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39138546 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39106754 |
| 65 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38576347 |
| 66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37113763 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36373823 |
| 68 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35958169 |
| 69 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.35729580 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35564069 |
| 71 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.34831670 |
| 72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32883519 |
| 73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31738929 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30220921 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29719077 |
| 76 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29605433 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29414261 |
| 78 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29323786 |
| 79 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.28840472 |
| 80 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.28184448 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26150352 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25984406 |
| 83 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.25613996 |
| 84 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.23981304 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22849863 |
| 86 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.22222740 |
| 87 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21777152 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21631529 |
| 89 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21332107 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21120589 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20770441 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20357869 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19732981 |
| 94 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19587326 |
| 95 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19578692 |
| 96 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19082262 |
| 97 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.18259843 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18144983 |
| 99 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17237953 |
| 100 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16441738 |
| 101 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16408242 |
| 102 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16068085 |
| 103 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15967022 |
| 104 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15325709 |
| 105 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14785305 |
| 106 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.14753085 |
| 107 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14677739 |
| 108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.14170380 |
| 109 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.13326959 |
| 110 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.13205123 |
| 111 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.12934836 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12618859 |
| 113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11898863 |
| 114 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11708773 |
| 115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11019177 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10822303 |
| 117 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.10780282 |
| 118 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10704105 |
| 119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10363358 |
| 120 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10289404 |
| 121 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09299844 |
| 122 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.08879746 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08160102 |
| 124 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08041258 |
| 125 | P300_27268052_Chip-Seq_Bcells_Human | 1.07468684 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06981630 |
| 127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06823540 |
| 128 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06758804 |
| 129 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06537494 |
| 130 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06319433 |
| 131 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05933473 |
| 132 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05661785 |
| 133 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.05649134 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05184193 |
| 135 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.04460796 |
| 136 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03647978 |
| 137 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01047700 |
| 138 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00200974 |
| 139 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99449184 |
| 140 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98508389 |
| 141 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97251404 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97157234 |
| 143 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96858031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.32376314 |
| 2 | MP0000685_abnormal_immune_system | 3.15587710 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 2.82072552 |
| 4 | MP0001800_abnormal_humoral_immune | 2.69716167 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.69539782 |
| 6 | MP0005387_immune_system_phenotype | 2.57802244 |
| 7 | MP0001790_abnormal_immune_system | 2.57802244 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.56682014 |
| 9 | MP0000749_muscle_degeneration | 2.43596670 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.37745862 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.36331738 |
| 12 | MP0005671_abnormal_response_to | 2.28338464 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.17424924 |
| 14 | MP0001873_stomach_inflammation | 2.13747471 |
| 15 | MP0003436_decreased_susceptibility_to | 2.12653934 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.08878634 |
| 17 | MP0002723_abnormal_immune_serum | 2.05097840 |
| 18 | MP0009785_altered_susceptibility_to | 2.02528083 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.01080329 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.99912126 |
| 21 | MP0002398_abnormal_bone_marrow | 1.98378350 |
| 22 | MP0001819_abnormal_immune_cell | 1.97082984 |
| 23 | MP0005310_abnormal_salivary_gland | 1.88411089 |
| 24 | MP0002106_abnormal_muscle_physiology | 1.84260339 |
| 25 | MP0000747_muscle_weakness | 1.82199898 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.76476875 |
| 27 | MP0000716_abnormal_immune_system | 1.74577690 |
| 28 | MP0005451_abnormal_body_composition | 1.74088639 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.71958606 |
| 30 | MP0005025_abnormal_response_to | 1.71251133 |
| 31 | MP0004381_abnormal_hair_follicle | 1.68621446 |
| 32 | MP0003646_muscle_fatigue | 1.67167961 |
| 33 | MP0002722_abnormal_immune_system | 1.67061948 |
| 34 | MP0000751_myopathy | 1.64088463 |
| 35 | MP0008260_abnormal_autophagy | 1.63014679 |
| 36 | MP0000759_abnormal_skeletal_muscle | 1.61067127 |
| 37 | MP0000733_abnormal_muscle_development | 1.60320818 |
| 38 | MP0002429_abnormal_blood_cell | 1.59751819 |
| 39 | MP0001853_heart_inflammation | 1.59366506 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.57677459 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.56966960 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.56095006 |
| 43 | MP0003693_abnormal_embryo_hatching | 1.52339333 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.48067302 |
| 45 | MP0002405_respiratory_system_inflammati | 1.45028662 |
| 46 | MP0005369_muscle_phenotype | 1.41677833 |
| 47 | MP0004947_skin_inflammation | 1.41392556 |
| 48 | MP0002419_abnormal_innate_immunity | 1.40263481 |
| 49 | MP0002269_muscular_atrophy | 1.39718817 |
| 50 | MP0002006_tumorigenesis | 1.38527069 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.35037645 |
| 52 | MP0000750_abnormal_muscle_regeneration | 1.34428429 |
| 53 | MP0003279_aneurysm | 1.34075732 |
| 54 | MP0008007_abnormal_cellular_replicative | 1.33638428 |
| 55 | MP0004087_abnormal_muscle_fiber | 1.31295393 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.29470723 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.28664078 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.28664078 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.27796640 |
| 60 | MP0004510_myositis | 1.27620815 |
| 61 | MP0003724_increased_susceptibility_to | 1.27432773 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.26256157 |
| 63 | MP0004036_abnormal_muscle_relaxation | 1.22601043 |
| 64 | MP0002933_joint_inflammation | 1.21597478 |
| 65 | MP0009278_abnormal_bone_marrow | 1.20639678 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.19748971 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.18613322 |
| 68 | MP0008058_abnormal_DNA_repair | 1.17590311 |
| 69 | MP0003077_abnormal_cell_cycle | 1.16638459 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.15688808 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.14320479 |
| 72 | MP0000490_abnormal_crypts_of | 1.13902674 |
| 73 | MP0002019_abnormal_tumor_incidence | 1.12668267 |
| 74 | MP0003705_abnormal_hypodermis_morpholog | 1.11786565 |
| 75 | MP0005360_urolithiasis | 1.11599214 |
| 76 | MP0001958_emphysema | 1.11041206 |
| 77 | MP0009764_decreased_sensitivity_to | 1.10355855 |
| 78 | MP0009384_cardiac_valve_regurgitation | 1.09712585 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.08722677 |
| 80 | MP0003866_abnormal_defecation | 1.08622847 |
| 81 | MP0001663_abnormal_digestive_system | 1.05314133 |
| 82 | MP0003111_abnormal_nucleus_morphology | 1.03891908 |
| 83 | MP0004130_abnormal_muscle_cell | 1.02843416 |
| 84 | MP0002653_abnormal_ependyma_morphology | 1.01868212 |
| 85 | MP0004858_abnormal_nervous_system | 1.01462072 |
| 86 | MP0008469_abnormal_protein_level | 1.01291148 |
| 87 | MP0001849_ear_inflammation | 0.97655198 |
| 88 | MP0008057_abnormal_DNA_replication | 0.97530239 |
| 89 | MP0005083_abnormal_biliary_tract | 0.94968944 |
| 90 | MP0000678_abnormal_parathyroid_gland | 0.92642489 |
| 91 | MP0005390_skeleton_phenotype | 0.92393161 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.92197608 |
| 93 | MP0004957_abnormal_blastocyst_morpholog | 0.91488632 |
| 94 | MP0003045_fibrosis | 0.90909082 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.90734522 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.90288157 |
| 97 | MP0004264_abnormal_extraembryonic_tissu | 0.89973252 |
| 98 | MP0000858_altered_metastatic_potential | 0.89674488 |
| 99 | MP0000343_altered_response_to | 0.88926673 |
| 100 | MP0003303_peritoneal_inflammation | 0.87662080 |
| 101 | MP0002132_abnormal_respiratory_system | 0.87169806 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.86910193 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.85248561 |
| 104 | MP0005023_abnormal_wound_healing | 0.85002012 |
| 105 | MP0000249_abnormal_blood_vessel | 0.84949438 |
| 106 | MP0010630_abnormal_cardiac_muscle | 0.84183249 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.83735587 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.82379829 |
| 109 | MP0000604_amyloidosis | 0.81870689 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.81678582 |
| 111 | MP0003448_altered_tumor_morphology | 0.81608286 |
| 112 | MP0009840_abnormal_foam_cell | 0.81223714 |
| 113 | MP0005058_abnormal_lysosome_morphology | 0.81090662 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.80942114 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.80488545 |
| 116 | MP0003075_altered_response_to | 0.80361418 |
| 117 | MP0005501_abnormal_skin_physiology | 0.80263378 |
| 118 | MP0010352_gastrointestinal_tract_polyps | 0.79558488 |
| 119 | MP0006082_CNS_inflammation | 0.78329077 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.77697840 |
| 121 | MP0000313_abnormal_cell_death | 0.77426436 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.75956808 |
| 123 | MP0002796_impaired_skin_barrier | 0.73677022 |
| 124 | MP0003567_abnormal_fetal_cardiomyocyte | 0.73307521 |
| 125 | MP0010234_abnormal_vibrissa_follicle | 0.73111380 |
| 126 | MP0000767_abnormal_smooth_muscle | 0.72717177 |
| 127 | MP0003795_abnormal_bone_structure | 0.72013057 |
| 128 | MP0005166_decreased_susceptibility_to | 0.70519895 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.70213104 |
| 130 | MP0003786_premature_aging | 0.69128427 |
| 131 | MP0003091_abnormal_cell_migration | 0.68213255 |
| 132 | MP0005381_digestive/alimentary_phenotyp | 0.68193471 |
| 133 | MP0002254_reproductive_system_inflammat | 0.67975243 |
| 134 | MP0000350_abnormal_cell_proliferation | 0.67258684 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.66665448 |
| 136 | MP0001243_abnormal_dermal_layer | 0.66485348 |
| 137 | MP0005620_abnormal_muscle_contractility | 0.65895573 |
| 138 | MP0003828_pulmonary_edema | 0.65843684 |
| 139 | MP0001879_abnormal_lymphatic_vessel | 0.64928297 |
| 140 | MP0002234_abnormal_pharynx_morphology | 0.64893858 |
| 141 | MP0002060_abnormal_skin_morphology | 0.63364526 |
| 142 | MP0001542_abnormal_bone_strength | 0.61916390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.77900343 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.52516917 |
| 3 | Nemaline bodies (HP:0003798) | 6.44131676 |
| 4 | Distal arthrogryposis (HP:0005684) | 5.53632315 |
| 5 | Ulnar deviation of the wrist (HP:0003049) | 5.43200776 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 5.26464381 |
| 7 | Myopathic facies (HP:0002058) | 5.09004316 |
| 8 | Round ear (HP:0100830) | 4.70124265 |
| 9 | Exercise-induced myalgia (HP:0003738) | 4.48270045 |
| 10 | Calcaneovalgus deformity (HP:0001848) | 4.41506402 |
| 11 | Deformed tarsal bones (HP:0008119) | 4.08962339 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 4.07697939 |
| 13 | Agammaglobulinemia (HP:0004432) | 3.86116550 |
| 14 | Dysostosis multiplex (HP:0000943) | 3.58318045 |
| 15 | J-shaped sella turcica (HP:0002680) | 3.53521402 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.48935037 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.38820143 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.38820143 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.38820143 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.23432455 |
| 21 | Absent phalangeal crease (HP:0006109) | 3.21701211 |
| 22 | Recurrent bronchitis (HP:0002837) | 3.15222168 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.14818262 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.14818262 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.14818262 |
| 26 | Chronic otitis media (HP:0000389) | 3.11111412 |
| 27 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.10774425 |
| 28 | Abnormality of the calcaneus (HP:0008364) | 3.04975569 |
| 29 | Muscle fiber splitting (HP:0003555) | 3.04315339 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 3.03329527 |
| 31 | Gastrointestinal stroma tumor (HP:0100723) | 3.01313944 |
| 32 | Thin bony cortex (HP:0002753) | 3.00333170 |
| 33 | Mucopolysacchariduria (HP:0008155) | 2.99787992 |
| 34 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.99787992 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.98300304 |
| 36 | Increased connective tissue (HP:0009025) | 2.95738922 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.95667557 |
| 38 | IgM deficiency (HP:0002850) | 2.93291823 |
| 39 | Colitis (HP:0002583) | 2.87330290 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.86696805 |
| 41 | Rhabdomyolysis (HP:0003201) | 2.82656615 |
| 42 | Petechiae (HP:0000967) | 2.80614659 |
| 43 | Malignant hyperthermia (HP:0002047) | 2.75229265 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.74628617 |
| 45 | Obstructive lung disease (HP:0006536) | 2.74454149 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74454149 |
| 47 | Recurrent viral infections (HP:0004429) | 2.73894662 |
| 48 | Frequent falls (HP:0002359) | 2.72080387 |
| 49 | Myoglobinuria (HP:0002913) | 2.70529148 |
| 50 | Orchitis (HP:0100796) | 2.70522851 |
| 51 | Difficulty running (HP:0009046) | 2.69675026 |
| 52 | Progressive muscle weakness (HP:0003323) | 2.68322549 |
| 53 | Abnormal finger flexion creases (HP:0006143) | 2.67545706 |
| 54 | Cellulitis (HP:0100658) | 2.66440741 |
| 55 | Stomatitis (HP:0010280) | 2.65664303 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.65643202 |
| 57 | Calf muscle hypertrophy (HP:0008981) | 2.65384341 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.65249300 |
| 59 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.64125409 |
| 60 | Muscle stiffness (HP:0003552) | 2.54644500 |
| 61 | EMG: myopathic abnormalities (HP:0003458) | 2.53108737 |
| 62 | Recurrent skin infections (HP:0001581) | 2.51988782 |
| 63 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.49404022 |
| 64 | Muscle fiber atrophy (HP:0100295) | 2.48753976 |
| 65 | Neck muscle weakness (HP:0000467) | 2.48718155 |
| 66 | Inflammation of the large intestine (HP:0002037) | 2.46999437 |
| 67 | Lymphopenia (HP:0001888) | 2.45345941 |
| 68 | Joint stiffness (HP:0001387) | 2.43094352 |
| 69 | Type 2 muscle fiber atrophy (HP:0003554) | 2.42322832 |
| 70 | Hemoptysis (HP:0002105) | 2.42132980 |
| 71 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42050487 |
| 72 | Hyporeflexia of lower limbs (HP:0002600) | 2.41962998 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.40537667 |
| 74 | Recurrent fungal infections (HP:0002841) | 2.38913756 |
| 75 | Optic neuritis (HP:0100653) | 2.37149821 |
| 76 | Retrobulbar optic neuritis (HP:0100654) | 2.37149821 |
| 77 | T lymphocytopenia (HP:0005403) | 2.35257037 |
| 78 | Increased IgE level (HP:0003212) | 2.34749806 |
| 79 | Malnutrition (HP:0004395) | 2.34214551 |
| 80 | Gastrointestinal infarctions (HP:0005244) | 2.34209854 |
| 81 | Difficulty climbing stairs (HP:0003551) | 2.33629327 |
| 82 | Autoimmune thrombocytopenia (HP:0001973) | 2.31789513 |
| 83 | Slender build (HP:0001533) | 2.31060339 |
| 84 | Recurrent abscess formation (HP:0002722) | 2.30152484 |
| 85 | Thrombocytosis (HP:0001894) | 2.29228706 |
| 86 | Abnormality of the neuromuscular junction (HP:0003398) | 2.28202387 |
| 87 | Fatigable weakness (HP:0003473) | 2.28202387 |
| 88 | Chronic diarrhea (HP:0002028) | 2.27787483 |
| 89 | Hemorrhage of the eye (HP:0011885) | 2.26222846 |
| 90 | Encephalitis (HP:0002383) | 2.25547417 |
| 91 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.24959279 |
| 92 | Subaortic stenosis (HP:0001682) | 2.24959279 |
| 93 | Abnormality of T cells (HP:0002843) | 2.24517913 |
| 94 | Abnormality of T cell number (HP:0011839) | 2.24059581 |
| 95 | Pustule (HP:0200039) | 2.23081263 |
| 96 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.22289973 |
| 97 | Emphysema (HP:0002097) | 2.22160674 |
| 98 | Weak cry (HP:0001612) | 2.21188816 |
| 99 | Areflexia of lower limbs (HP:0002522) | 2.20543298 |
| 100 | Facial diplegia (HP:0001349) | 2.19675411 |
| 101 | Nasal polyposis (HP:0100582) | 2.17179614 |
| 102 | Meningitis (HP:0001287) | 2.17014202 |
| 103 | Mesangial abnormality (HP:0001966) | 2.16896341 |
| 104 | Asymmetric septal hypertrophy (HP:0001670) | 2.16895947 |
| 105 | Cervical subluxation (HP:0003308) | 2.16737873 |
| 106 | Verrucae (HP:0200043) | 2.09813450 |
| 107 | Papilloma (HP:0012740) | 2.09813450 |
| 108 | Increased serum ferritin (HP:0003281) | 2.09667714 |
| 109 | Hematochezia (HP:0002573) | 2.09434709 |
| 110 | Prolonged bleeding time (HP:0003010) | 2.09407082 |
| 111 | Chest pain (HP:0100749) | 2.09324963 |
| 112 | Systemic lupus erythematosus (HP:0002725) | 2.07884382 |
| 113 | Abnormality of the nasal mucosa (HP:0000433) | 2.07755116 |
| 114 | Gingivitis (HP:0000230) | 2.06913931 |
| 115 | Recurrent bacterial skin infections (HP:0005406) | 2.06348867 |
| 116 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05293505 |
| 117 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05293505 |
| 118 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.04793498 |
| 119 | Eczematoid dermatitis (HP:0000976) | 2.03535938 |
| 120 | Myositis (HP:0100614) | 2.02727866 |
| 121 | Loss of speech (HP:0002371) | 2.01420936 |
| 122 | Spontaneous hematomas (HP:0007420) | 1.98174564 |
| 123 | Hypergammaglobulinemia (HP:0010702) | 1.96965646 |
| 124 | Reticulocytopenia (HP:0001896) | 1.95124614 |
| 125 | Increased IgM level (HP:0003496) | 1.93686994 |
| 126 | Vasculitis (HP:0002633) | 1.92102301 |
| 127 | Stridor (HP:0010307) | 1.91198243 |
| 128 | Distal lower limb muscle weakness (HP:0009053) | 1.90872537 |
| 129 | Granulocytopenia (HP:0001913) | 1.90626216 |
| 130 | Myotonia (HP:0002486) | 1.89912293 |
| 131 | Abnormality of B cell number (HP:0010975) | 1.89467138 |
| 132 | Restrictive lung disease (HP:0002091) | 1.89280503 |
| 133 | Microretrognathia (HP:0000308) | 1.87782231 |
| 134 | Pelvic girdle muscle weakness (HP:0003749) | 1.87545946 |
| 135 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.86377925 |
| 136 | Rimmed vacuoles (HP:0003805) | 1.84198984 |
| 137 | Generalized muscle weakness (HP:0003324) | 1.84192413 |
| 138 | Bulbar palsy (HP:0001283) | 1.83892994 |
| 139 | Abnormality of the pleura (HP:0002103) | 1.83874639 |
| 140 | Sepsis (HP:0100806) | 1.83595387 |
| 141 | Recurrent sinusitis (HP:0011108) | 1.82597884 |
| 142 | Prolonged neonatal jaundice (HP:0006579) | 1.82384550 |
| 143 | Broad face (HP:0000283) | 1.81799821 |
| 144 | IgG deficiency (HP:0004315) | 1.81376159 |
| 145 | B lymphocytopenia (HP:0010976) | 1.81055635 |
| 146 | Increased variability in muscle fiber diameter (HP:0003557) | 1.80150416 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.78650609 |
| 148 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.78628958 |
| 149 | Short palpebral fissure (HP:0012745) | 1.78162726 |
| 150 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77172313 |
| 151 | Lymphangioma (HP:0100764) | 1.76850872 |
| 152 | Hypertensive crisis (HP:0100735) | 1.76540680 |
| 153 | Bronchitis (HP:0012387) | 1.75704717 |
| 154 | Easy fatigability (HP:0003388) | 1.75509905 |
| 155 | Thoracic kyphosis (HP:0002942) | 1.73735368 |
| 156 | Recurrent lower respiratory tract infections (HP:0002783) | 1.73685598 |
| 157 | Arthralgia (HP:0002829) | 1.73429549 |
| 158 | Abnormal number of erythroid precursors (HP:0012131) | 1.72227962 |
| 159 | Autoimmune hemolytic anemia (HP:0001890) | 1.71932307 |
| 160 | Epistaxis (HP:0000421) | 1.71689861 |
| 161 | Deformed sella turcica (HP:0002681) | 1.71682911 |
| 162 | Osteomyelitis (HP:0002754) | 1.71366125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.79603482 |
| 2 | MAP4K1 | 4.07882800 |
| 3 | TTN | 3.07477251 |
| 4 | OBSCN | 2.92530880 |
| 5 | ERN1 | 2.64479988 |
| 6 | MAP2K3 | 2.43341688 |
| 7 | TYK2 | 2.29182451 |
| 8 | PIK3CG | 2.24073903 |
| 9 | TEC | 2.04093135 |
| 10 | TNK2 | 2.01363077 |
| 11 | JAK3 | 1.99977841 |
| 12 | RIPK4 | 1.96584200 |
| 13 | NME2 | 1.93653791 |
| 14 | MAP3K10 | 1.91303038 |
| 15 | KIT | 1.87737438 |
| 16 | STK10 | 1.87038154 |
| 17 | IRAK3 | 1.84689582 |
| 18 | BTK | 1.75611889 |
| 19 | EEF2K | 1.74692933 |
| 20 | TRIB3 | 1.73707735 |
| 21 | BLK | 1.71999561 |
| 22 | TAOK3 | 1.67241522 |
| 23 | TBK1 | 1.60259277 |
| 24 | SMG1 | 1.56417790 |
| 25 | ZAP70 | 1.55388080 |
| 26 | KDR | 1.49315468 |
| 27 | TAOK1 | 1.44829744 |
| 28 | IKBKE | 1.43523275 |
| 29 | CSF1R | 1.42671191 |
| 30 | LRRK2 | 1.38237738 |
| 31 | FLT3 | 1.37393708 |
| 32 | FES | 1.34822812 |
| 33 | CDC42BPA | 1.29969626 |
| 34 | PRPF4B | 1.28898998 |
| 35 | MAP2K2 | 1.25129359 |
| 36 | PHKG1 | 1.22224000 |
| 37 | PHKG2 | 1.22224000 |
| 38 | SYK | 1.19759422 |
| 39 | MAP3K7 | 1.17919793 |
| 40 | NME1 | 1.17780021 |
| 41 | TGFBR2 | 1.16883354 |
| 42 | MAP2K6 | 1.16850252 |
| 43 | BCKDK | 1.16409305 |
| 44 | GRK6 | 1.16132837 |
| 45 | FGFR4 | 1.16039194 |
| 46 | TXK | 1.15626232 |
| 47 | IRAK4 | 1.12812909 |
| 48 | SIK2 | 1.11535346 |
| 49 | TLK1 | 1.07770771 |
| 50 | NEK9 | 1.05698312 |
| 51 | JAK1 | 1.03960585 |
| 52 | PKN2 | 1.03497365 |
| 53 | MARK3 | 1.02039041 |
| 54 | NEK2 | 1.01579761 |
| 55 | PIM2 | 1.01289202 |
| 56 | TGFBR1 | 1.01087615 |
| 57 | MAP3K14 | 1.00970474 |
| 58 | IKBKB | 1.00174704 |
| 59 | MAP3K11 | 0.99306498 |
| 60 | DYRK3 | 0.98557435 |
| 61 | SIK3 | 0.96812461 |
| 62 | TESK1 | 0.96300513 |
| 63 | RPS6KB2 | 0.96062402 |
| 64 | ACVR1B | 0.94740838 |
| 65 | PIM1 | 0.94494444 |
| 66 | MAPKAPK3 | 0.94404709 |
| 67 | MAPK11 | 0.94096629 |
| 68 | RPS6KA4 | 0.92938357 |
| 69 | MAPK12 | 0.92556762 |
| 70 | RPS6KA2 | 0.91667092 |
| 71 | HIPK2 | 0.91088583 |
| 72 | GRK1 | 0.89557109 |
| 73 | TAOK2 | 0.87028151 |
| 74 | MAP3K3 | 0.86851855 |
| 75 | ITK | 0.85911734 |
| 76 | MARK2 | 0.83664644 |
| 77 | RPS6KC1 | 0.82786790 |
| 78 | RPS6KL1 | 0.82786790 |
| 79 | MAPK15 | 0.81787143 |
| 80 | CAMK1D | 0.81451924 |
| 81 | EPHB1 | 0.80654673 |
| 82 | MAP3K13 | 0.77823091 |
| 83 | LCK | 0.76809761 |
| 84 | RPS6KA6 | 0.76201603 |
| 85 | RIPK1 | 0.74386275 |
| 86 | STK16 | 0.73175383 |
| 87 | NLK | 0.73122814 |
| 88 | MAP3K1 | 0.71936683 |
| 89 | HCK | 0.71290332 |
| 90 | LYN | 0.70566343 |
| 91 | BUB1 | 0.70235539 |
| 92 | PDPK1 | 0.69577699 |
| 93 | MATK | 0.69270861 |
| 94 | BMX | 0.68642521 |
| 95 | CSK | 0.68611965 |
| 96 | TSSK6 | 0.66036803 |
| 97 | CDK4 | 0.65003479 |
| 98 | EIF2AK3 | 0.62589168 |
| 99 | PRKCQ | 0.62323244 |
| 100 | IRAK1 | 0.61607700 |
| 101 | PDK1 | 0.60853575 |
| 102 | TRPM7 | 0.60704458 |
| 103 | SRPK1 | 0.60192051 |
| 104 | GRK7 | 0.58551244 |
| 105 | MAPK7 | 0.58297138 |
| 106 | MUSK | 0.55462561 |
| 107 | MAPKAPK2 | 0.52106082 |
| 108 | DYRK1B | 0.50957875 |
| 109 | IRAK2 | 0.50726952 |
| 110 | MAP3K8 | 0.49771984 |
| 111 | PRKG2 | 0.49633691 |
| 112 | CHUK | 0.48388717 |
| 113 | MAP3K6 | 0.47233236 |
| 114 | PRKD1 | 0.45735638 |
| 115 | CDK7 | 0.45568488 |
| 116 | SIK1 | 0.45197031 |
| 117 | PAK4 | 0.44699223 |
| 118 | ADRBK2 | 0.44617940 |
| 119 | PRKD3 | 0.41925221 |
| 120 | PTK6 | 0.41466908 |
| 121 | PASK | 0.41446102 |
| 122 | TESK2 | 0.40280466 |
| 123 | PIK3CA | 0.39864550 |
| 124 | MAPK4 | 0.38956055 |
| 125 | ICK | 0.37515735 |
| 126 | CAMKK1 | 0.37179969 |
| 127 | PRKD2 | 0.35915916 |
| 128 | CAMK1G | 0.35828921 |
| 129 | PRKCI | 0.34819349 |
| 130 | WEE1 | 0.34627786 |
| 131 | CLK1 | 0.34404719 |
| 132 | ILK | 0.29327030 |
| 133 | JAK2 | 0.28331937 |
| 134 | PINK1 | 0.27799788 |
| 135 | EPHA2 | 0.26945331 |
| 136 | PRKAA2 | 0.25799643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.02191990 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.99360522 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.78057364 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.75696407 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.73470947 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.67545701 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.35057230 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.24856572 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.10706257 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09245790 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08023735 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.01511806 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93855392 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82703737 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.82657204 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80258375 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.79281874 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.72613915 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70114352 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.63896358 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.60236573 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.49543310 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48763530 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47734997 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.44368251 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.36388297 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.35063192 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.32090107 |
| 29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31965391 |
| 30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.31538254 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.30784024 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.28803765 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.27868853 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26559462 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25566102 |
| 36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.24772960 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23538277 |
| 38 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20617314 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20036699 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.19041753 |
| 41 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17545225 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14971002 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13821614 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13584440 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.09308733 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08678820 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08382723 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.07728472 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06317757 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03493290 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 1.00306583 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00150791 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97994535 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97341010 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97002651 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96225525 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.95520042 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.90123135 |
| 59 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.89798215 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88717726 |
| 61 | Cell cycle_Homo sapiens_hsa04110 | 0.87537703 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.87433932 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86945441 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84137603 |
| 65 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.82164439 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.80967084 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80052335 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78171589 |
| 69 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77826794 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.77359054 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76436125 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76107601 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.72485005 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.71907875 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71384024 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.71115353 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.69730950 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67768610 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67737155 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.67509812 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67249267 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67180857 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.67023919 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66454495 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66129424 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65969927 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65635406 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.65447812 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65178602 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63420801 |
| 91 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62196854 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61613322 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60967329 |
| 94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60626242 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60476613 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60143344 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58758341 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58128590 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58057714 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.56838252 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56538578 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56420196 |
| 103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56054958 |
| 104 | ABC transporters_Homo sapiens_hsa02010 | 0.55064374 |
| 105 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54256004 |
| 106 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54042654 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.52799618 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49506402 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49246290 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49188683 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49130410 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48972286 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47930227 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47200669 |
| 115 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46136197 |
| 116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45698684 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45557238 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43360395 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43020629 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41904427 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41878803 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41795752 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41424559 |
| 124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40837924 |
| 125 | Salmonella infection_Homo sapiens_hsa05132 | 0.40330515 |
| 126 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.39325826 |
| 127 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39160977 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38917265 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38021569 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37543455 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37229704 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36340182 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36079282 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35425034 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35214291 |
| 136 | Basal transcription factors_Homo sapiens_hsa03022 | 0.34800511 |
| 137 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34288810 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33937676 |
| 139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33455063 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30111415 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27588468 |
| 142 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26577557 |

